Nora BE .35 mg/1

Nora BE .35 mg/1 is a progestin-only birth control tablet containing norethindrone. It is used for contraception and may help regulate menstrual cycles. This oral medication is manufactured by Teva Pharmaceuticals, Inc. in the USA.

Nora BE .35 mg/1 is primarily used as a form of birth control. It works by preventing ovulation and altering the cervical mucus to hinder sperm movement. Some individuals may also use it to manage menstrual irregularities or reduce heavy bleeding. The primary active ingredient, norethindrone, is a synthetic progestin that mimics the natural hormone progesterone.

Common effects of Nora BE .35 mg/1 may include changes in menstrual bleeding patterns, such as lighter or more frequent periods. Some users may experience headaches, breast tenderness, or nausea. These effects vary among individuals and typically subside as the body adjusts to the medication.

Nora BE .35 mg/1 should be used as directed by a healthcare provider. It is important to inform your healthcare provider about any existing medical conditions or allergies. This medication may not be suitable for everyone, particularly those with a history of blood clots or liver disease.

Nora BE .35 mg/1 may interact with certain medications, including those that induce liver enzymes like rifampin or certain anticonvulsants. It is advisable to consult a healthcare provider before combining it with other medications. Alcohol consumption should be moderated, as it may affect the efficacy of the medication.